Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. The benefits of oral immunotherapy for food allergies have been demonstrated by successful treatment of thousands of patients both in private practice and in studies for the past few decades, primarily in the United States. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Based on the Allergy Immunotherapies market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Allergy Immunotherapies market covered in Chapter 5:
Anergis
Biomay
Sementis
Shionogi
Adamis Pharmaceuticals
HAL Allergy
ASIT biotech
DBV Technologies
Nycomed
Verona Pharma
Torii
VentiRx Pharmaceuticals
Laboratorios LETI
Aimmune Therapeutics
Genentech
Circassia
Tunitas Therapeutics
Mitsubishi Tanabe Pharma
In Chapter 6, on the basis of types, the Allergy Immunotherapies market from 2015 to 2025 is primarily split into:
Subcutaneous Immunotherapy
Sublingual Immunotherapy
In Chapter 7, on the basis of applications, the Allergy Immunotherapies market from 2015 to 2025 covers:
Allergic Rhinitis
Allergic Asthma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
2019
Based on the Allergy Immunotherapies market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Allergy Immunotherapies market covered in Chapter 5:
Anergis
Biomay
Sementis
Shionogi
Adamis Pharmaceuticals
HAL Allergy
ASIT biotech
DBV Technologies
Nycomed
Verona Pharma
Torii
VentiRx Pharmaceuticals
Laboratorios LETI
Aimmune Therapeutics
Genentech
Circassia
Tunitas Therapeutics
Mitsubishi Tanabe Pharma
In Chapter 6, on the basis of types, the Allergy Immunotherapies market from 2015 to 2025 is primarily split into:
Subcutaneous Immunotherapy
Sublingual Immunotherapy
In Chapter 7, on the basis of applications, the Allergy Immunotherapies market from 2015 to 2025 covers:
Allergic Rhinitis
Allergic Asthma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.